Holen Sie sich die Stockscreener-App
42.20
2.06%
0.85
Handel nachbörslich:
42.00
-0.20
-0.47%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$41.35
Offen:
$40.99
24-Stunden-Volumen:
1.08M
Relative Volume:
0.92
Marktkapitalisierung:
$2.24B
Einnahmen:
$238.11M
Nettoeinkommen (Verlust:
$-31.45M
KGV:
-66.62
EPS:
-0.6334
Netto-Cashflow:
$7.66M
1W Leistung:
+6.86%
1M Leistung:
-8.64%
6M Leistung:
+21.09%
1J Leistung:
+222.38%
1-Tages-Spanne:
$39.92
$42.78
1-Wochen-Bereich:
$38.31
$46.15
52-Wochen-Spanne:
$12.38
$46.95
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Compare AXGN vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
42.20 | 2.19B | 238.11M | -31.45M | 7.66M | -0.6334 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-19 | Eingeleitet | Wells Fargo | Overweight |
| 2025-12-01 | Eingeleitet | Mizuho | Outperform |
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Axogen earnings on deck as nerve repair reimbursement gains gather steam - Investing.com UK
AxoGen Inc (AXGN) Institutional Confidence - TradingKey
AxoGen Inc (AXGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AxoGen Inc (AXGN) Valuation: PE, PB & Fair Value Analysis - TradingKey
234,495 Shares in AxoGen, Inc. $AXGN Acquired by SummitTX Capital L.P. - MarketBeat
First Light Asset Management LLC Has $132.61 Million Stock Holdings in AxoGen, Inc. $AXGN - MarketBeat
AxoGen Inc (AXGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AxoGen Inc (AXGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AxoGen Inc (AXGN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AxoGen Inc (AXGN) Cash Flow - TradingKey
Wall Street Zen Upgrades AxoGen (NASDAQ:AXGN) to Buy - MarketBeat
TradingKey - TradingKey
AxoGen Inc (AXGN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AXGN|AxoGen Inc|Price:41.130|Chg%:+1.640 - TradingKey
AXGN|AxoGen Inc|Price:39.490|Chg%:-0.240 - TradingKey
Axogen Inc. (AXGN) Q1 2026 Earnings: EPS Falls Short of Estimates, Stock Edges LowerROIC Trend Report - dars.gov.et
AxoGen Inc (AXGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Earnings Preview: AxoGen to Report Financial Results Pre-market on July 29 - Moomoo
Does NZS Capital’s ‘Optionality’ Stake and Coverage Momentum Change The Bull Case For Axogen (AXGN)? - simplywall.st
Axogen Inc. (AXGN) Consolidates Near $39.40 as Volume Points to Potential BreakoutStock Buy Zone - dars.gov.et
AxoGen (AXGN) Projected to Release Quarterly Earnings on Wednesday - MarketBeat
NZS Capital Added Axogen (AXGN) as an Optionality Position - Yahoo Finance
WCM Investment Management LLC Acquires 158,914 Shares of AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Rating Lowered to Hold at Wall Street Zen - MarketBeat
(AXGN) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 - Sahm
Axogen to report Q2 2026 financial results on J... - Pluang
Aubrey Capital Management Ltd Invests $2.88 Million in AxoGen, Inc. $AXGN - MarketBeat
Axogen Inc. (AXGN) Q1 2026 Earnings: Slight EPS Miss Highlights Cost PressuresQuarterly Profit Report - dars.gov.et
Axogen Insiders Sold US$6.2m Of Shares Suggesting Hesitancy - Moomoo
What Axogen (AXGN)'s Russell Index Removal Means For Shareholders - simplywall.st
Jefferies Maintains AxoGen(AXGN.US) With Buy Rating, Raises Target Price to $50 - Moomoo
AXGN Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesNet Profit Margin - dars.gov.et
Axogen Inc. (AXGN) Q1 2026 Earnings: Narrow EPS Miss and Positive Stock Reaction Signal Cautious Optimism - dars.gov.et
Axogen stock hits 52-week high at 46.05 USD - Investing.com UK
Axogen stock hits 52-week high at 46.05 USD By Investing.com - Investing.com Nigeria
Will Axogen’s (AXGN) Russell Index Removal Reshape Its Liquidity Profile and Risk‑Reward Narrative? - Sahm
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Index - marketscreener.com
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Price to earnings forward of Axogen, Inc. – NASDAQ:AXGN - TradingView
Axogen, Inc.(NasdaqCM: AXGN) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Daily Brief Health Care: AxoGen Inc, Dentsply International and more - Smartkarma
Axogen Inc. (AXGN) Edges Higher as Shares Test Key Resistance at $47.18Wyckoff Distribution - dars.gov.et
Form 4 Axogen Inc For: 26 June By Investing.com - Investing.com Nigeria
AXGN News | AXOGEN INC (NASDAQ:AXGN) - ChartMill
Axogen (AXGN) director receives 4,392 restricted stock units in annual equity grant - Stock Titan
Axogen (AXGN) director Alan Levine granted 4,392 RSUs valued at $185K - Stock Titan
Axogen (AXGN) director receives 4,392 RSUs in $185,000 equity grant - Stock Titan
Axogen (AXGN) director Wendell McBride awarded 4,392 RSUs valued at $185,000 - Stock Titan
Q4 2025 AxoGen Inc Earnings Call Transcript - GuruFocus
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Axogen Inc-Aktie (AXGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weiler Kathy Johnson | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,150 |
| Wendell Amy McBride | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
107,976 |
| THOMAS PAUL | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
18,867 |
0 |
32,395 |
| TYNDALL JOSEPH A. | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,150 |
| JOHNSON JOHN | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,150 |
| Burke William P. Mr. | Director |
Jun 19 '26 |
Option Exercise |
0.00 |
14,150 |
0 |
14,250 |
| Wendell Amy McBride | Director |
May 08 '26 |
Option Exercise |
14.85 |
1,647 |
24,458 |
95,473 |
| Wendell Amy McBride | Director |
May 08 '26 |
Sale |
42.60 |
1,647 |
70,162 |
93,826 |
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):